Cargando…
The anti-fibrotic effect of human fetal skin-derived stem cell secretome on the liver fibrosis
BACKGROUND: Liver fibrosis resulting from chronic liver injury is one of the major causes of mortality worldwide. Stem cell-secreted secretome has been evaluated for overcoming the limitations of cell-based therapy in hepatic disease, while maintaining its advantages. METHODS: In this study, we inve...
Autores principales: | Yao, Xia, Wang, Jing, Zhu, Jiajing, Rong, Xiaoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650526/ https://www.ncbi.nlm.nih.gov/pubmed/32883340 http://dx.doi.org/10.1186/s13287-020-01891-5 |
Ejemplares similares
-
Identification of MFGE8 in mesenchymal stem cell secretome as an anti-fibrotic factor in liver fibrosis
por: Jang, Yu Jin, et al.
Publicado: (2017) -
Human fetal skin-derived stem cell secretome enhances radiation-induced skin injury therapeutic effects by promoting angiogenesis
por: Rong, Xiaoli, et al.
Publicado: (2019) -
A Novel Hepatic Anti-Fibrotic Strategy Utilizing the Secretome Released from Etanercept-Synthesizing Adipose-Derived Stem Cells
por: Han, Jae Hyun, et al.
Publicado: (2019) -
Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars
por: Vanderstichele, Sophie, et al.
Publicado: (2022) -
Defining the Cardiac Fibroblast Secretome in a Fibrotic Microenvironment
por: Ceccato, Tova L., et al.
Publicado: (2020)